BACKGROUND: Gastric carcinomas can be divided into intestinal and diffuse types, with the last type having a worse prognosis. AIMS: To investigate whether specific patterns in the expression of apoptosis related proteins correlate with carcinoma type and/or prognosis METHODS: The expression of Fas, Bcl-2, Bax, Bcl-xl, cyclooxygenase-2 (COX-2), and inducible nitric oxide synthase (iNOS) was studied immunohistochemically and the extent of apoptosis and proliferation was investigated in 11 cases of intestinal type and in eight cases of diffuse type carcinoma. RESULTS: Fas was expressed in all intestinal type and in one diffuse type carcinoma. Bcl-xl was expressed in 10 of 11 intestinal type and in one of eight diffuse type carcinomas. Bcl-2 was expressed in lamina propria immune cells. iNOS was expressed in six of 11 intestinal type and in four of eight diffuse type carcinomas, and COX-2 was expressed in eight of 11 intestinal type and in six of eight diffuse type carcinomas. CONCLUSION: Fas and Bcl-xl expression can differentiate between intestinal type and diffuse type gastric carcinomas. No differences in apoptosis and proliferation between intestinal type and diffuse type gastric carcinomas were observed.
BACKGROUND:Gastric carcinomas can be divided into intestinal and diffuse types, with the last type having a worse prognosis. AIMS: To investigate whether specific patterns in the expression of apoptosis related proteins correlate with carcinoma type and/or prognosis METHODS: The expression of Fas, Bcl-2, Bax, Bcl-xl, cyclooxygenase-2 (COX-2), and inducible nitric oxide synthase (iNOS) was studied immunohistochemically and the extent of apoptosis and proliferation was investigated in 11 cases of intestinal type and in eight cases of diffuse type carcinoma. RESULTS:Fas was expressed in all intestinal type and in one diffuse type carcinoma. Bcl-xl was expressed in 10 of 11 intestinal type and in one of eight diffuse type carcinomas. Bcl-2 was expressed in lamina propria immune cells. iNOS was expressed in six of 11 intestinal type and in four of eight diffuse type carcinomas, and COX-2 was expressed in eight of 11 intestinal type and in six of eight diffuse type carcinomas. CONCLUSION:Fas and Bcl-xl expression can differentiate between intestinal type and diffuse type gastric carcinomas. No differences in apoptosis and proliferation between intestinal type and diffuse type gastric carcinomas were observed.
Authors: Marieke H Schoemaker; Jenny E Ros; Manon Homan; Christian Trautwein; Peter Liston; Klaas Poelstra; Harry van Goor; Peter L M Jansen; Han Moshage Journal: J Hepatol Date: 2002-06 Impact factor: 25.083
Authors: Maria D Begnami; Andre L Montagnini; Andre L Vettore; Sueli Nonogaki; Mariana Brait; Alex Y Simoes-Sato; Andrea Q A Seixas; Fernando A Soares Journal: World J Gastroenterol Date: 2006-08-21 Impact factor: 5.742
Authors: Cesar Cilento Ponce; Maria de Lourdes F Chauffaille; Silvia Saiuli M Ihara; Maria Regina R Silva Journal: Med Oncol Date: 2011-12-27 Impact factor: 3.064
Authors: J Malta-Vacas; C Aires; P Costa; A R Conde; S Ramos; A P Martins; C Monteiro; M Brito Journal: J Clin Pathol Date: 2005-06 Impact factor: 3.411
Authors: Mariusz Gryko; Anna Pryczynicz; Konrad Zareba; Bogusław Kędra; Andrzej Kemona; Katarzyna Guzińska-Ustymowicz Journal: J Immunol Res Date: 2014-02-19 Impact factor: 4.818
Authors: Cesar Cilento Ponce; Maria de Lourdes Lopes Ferrari Chauffaille; Silvia Saiuli Miki Ihara; Maria Regina Regis Silva Journal: Rev Bras Hematol Hemoter Date: 2014-07-18